咖啡酸乙烯:揭示其作为一种强有力的亡诱导剂的潜力,用于对抗下甲状腺状细胞癌
Hyun-Ji Kim1, Min-Hye Ahn2, Ji-Ae Shin3
1Department of Oral Pathology, School of Dentistry and Dental Research Institute, Seoul National University, Seoul 03080, Republic of Korea.
Oncology reports
|December 15, 2023
概括
咖啡酸乙烯 (CAPE) 在治疗低喉皮状细胞癌 (HSCC) 中表现有前途. 这种化合物通过诱导亡,有效地抑制HSCC瘤的生长,提供了潜在的新治疗途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低甲状腺状细胞癌 (HSCC) 由于预后不佳和治疗选择有限,因此具有重大临床挑战.
- 对于改善HSCC患者的生存率的新型治疗策略的需求尚未得到满足.
研究的目的:
- 调查咖啡酸乙烯 (CAPE) 的抗癌作用,这是一种衍生物化合物,对HSCC.
- 阐明CAPE在HSCC中的瘤抑制活性背后的分子机制.
主要方法:
- 评估CAPE对HSCC细胞活力和亡诱导的影响.
- 分析线粒体膜潜力和caspase-9激活.
- 对CAPE对亡抑制剂表达的影响的评估,包括幸存者和X关联亡抑制剂 (XIAP).
主要成果:
- 在HSCC细胞系中,CAPE显示出显著的瘤抑制活性.
- 通过破坏线粒体膜潜能和激活caspase-9.9,CAPE治疗诱导了亡.
- CAPE调节了关键的亡抑制剂,幸存者和XIAP的表达,导致癌细胞死亡.
结论:
- 咖啡酸乙烯 (CAPE) 通过触发线粒体依赖的亡,有效抑制HSCC的生长.
- CAPE代表了下甲状腺状细胞癌的潜在治疗剂,需要进一步的临床研究.
相关概念视频
Phagocytosis of Apoptotic Cells
3.8K
Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or immature dendritic cells. Non-professional phagocytes such as epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes.
Normal cells contain receptors that prevent them from being recognized...
Normal cells contain receptors that prevent them from being recognized...
3.8K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K


